Solyco Capital is a private equity and advisory firm based in Rochester, Michigan, founded in 2017. The firm specializes in delivering capital solutions for late-stage startups and growth companies, as well as providing comprehensive financial advisory services to middle-market enterprises. In addition to capital formation and management consulting, Solyco Capital offers strategic advisory services related to real estate investments, financing, and mergers and acquisitions. With a focus on supporting the growth and development of its clients, Solyco Capital aims to facilitate successful financial transactions and enhance business operations.
Global Gaming League is a professional gaming entertainment organization that operates an online platform offering video game tournaments and events for a global audience of all ages. It aims to provide an unrivaled entertainment experience, drawing inspiration from the structure and competitiveness of professional sports leagues like the NFL.
SkyMirr
Series A in 2025
SkyMirr, founded in 2021 and based in Satellite Beach, Florida, specializes in innovative radio frequency (RF) technology aimed at enhancing both telecommunications and medical applications. The company develops products that improve broadband wireless communication, allowing clients to deliver cost-effective and high-performing services to consumers. In addition, SkyMirr's RF technology is designed to advance medical treatments, offering solutions that address serious diseases more effectively. Through its commitment to improving human life, SkyMirr is positioned at the intersection of technology and healthcare, contributing to advancements in both fields.
FluidLogic
Series A in 2024
FluidLogic is a company focused on developing high-performance active hydration systems aimed at enhancing hydration for individuals in demanding environments, such as motorsports. Their product lineup includes the FluidLogic Flush 360 Assembly and the FluidLogic WAVE, which are vehicle-mounted systems that facilitate easy access to hydration on the move. Additionally, FluidLogic offers various accessories, including the Coaxial Helmet Side Kit and the Flush 360 Helmet Side Kit, to complement their hydration solutions. The company's innovative air delivery system optimally routes hydration to users through a programmable application, utilizing a magnetic coupling device to ensure timely access to water. FluidLogic is dedicated to empowering individuals with the knowledge and tools necessary to achieve peak cognitive and physical performance through effective hydration.
OSDB
Seed Round in 2023
OSDB operates a digital sports media platform that offers comprehensive, verified information about professional athletes and their teams. The platform aggregates data on athletes' agents, contracts, business ventures, endorsements, philanthropy, and more, along with team front office information and relevant contacts. This enables businesses to connect with athletes and teams for endorsement deals and partnerships. OSDB has raised a total of $5.5 million in funding, including a $2.5 million seed round currently in progress.
Toralgen
Seed Round in 2020
Toralgen, Inc. is a preclinical stage biopharmaceutical company based in Indianapolis, Indiana, focused on developing innovative drug delivery technologies. Founded in 2017, the company specializes in a polybile nanopill platform designed to enhance the oral administration of therapeutics. This technology addresses the common challenges associated with oral drug delivery by enabling the targeted delivery of active pharmaceutical compounds to specific sites within the body. By improving the efficacy and safety of therapies, Toralgen aims to enhance patient outcomes and facilitate the commercialization of human therapeutics.
Toralgen
Seed Round in 2019
Toralgen, Inc. is a preclinical stage biopharmaceutical company based in Indianapolis, Indiana, focused on developing innovative drug delivery technologies. Founded in 2017, the company specializes in a polybile nanopill platform designed to enhance the oral administration of therapeutics. This technology addresses the common challenges associated with oral drug delivery by enabling the targeted delivery of active pharmaceutical compounds to specific sites within the body. By improving the efficacy and safety of therapies, Toralgen aims to enhance patient outcomes and facilitate the commercialization of human therapeutics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.